Company
Diaceutics PLC
LON:DXRX
Diaceutics has established a suite of data-driven products and implementation services powered by the data held in its proprietary database. Its products and services are focused on optimising its clients' strategies for the development and launch of precision medicines and specifically, the diagnostic testing required to guide selection of such medicines. The Company currently provides services to 20 of the 30 largest global pharmaceutical companies.
7 stories
How de-equitisation could be both a good and bad thing for investors
A lack of new listings on the London market coupled with some large-scale collapses, acquisitions and share buybacks have led to the pool of equities looking more like a puddle
Diaceutics sets out stall to dominate precision medicine test market
Diaceutics tests patients for precision medicines (or therapies), a class of drug tailored to individual patient groups
Diaceutics makes bright start on AIM debut
Placed at 76p, the shares were trading at 87.5p in first dealings